These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 31736241)

  • 1. Intravenous immunoglobulin therapy enhances suppressive regulatory T cells and decreases innate lymphoid cells in children with immune thrombocytopenia.
    Wang SC; Yang KD; Lin CY; Huang AY; Hsiao CC; Lin MT; Tsai YG
    Pediatr Blood Cancer; 2020 Feb; 67(2):e28075. PubMed ID: 31736241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutralizations of IL-17A and IL-21 regulate regulatory T cell/T-helper 17 imbalance via T-helper 17-associated signaling pathway in immune thrombocytopenia.
    Hu Y; Wang X; Yu S; Hou Y; Ma D; Hou M
    Expert Opin Ther Targets; 2015 Jun; 19(6):723-32. PubMed ID: 25976230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered distribution and function of splenic innate lymphoid cells in adult chronic immune thrombocytopenia.
    Audia S; Moulinet T; Ciudad-Bonté M; Samson M; Facy O; Ortega-Deballon P; Saas P; Bonnotte B
    J Autoimmun; 2018 Sep; 93():139-144. PubMed ID: 30055825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional role of CD4+CD25+ regulatory T cells and transforming growth factor-beta1 in childhood immune thrombocytopenic purpura.
    Fahim NM; Monir E
    Egypt J Immunol; 2006; 13(1):173-87. PubMed ID: 17974160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insufficient secretion of IL-10 by Tregs compromised its control on over-activated CD4+ T effector cells in newly diagnosed adult immune thrombocytopenia patients.
    Li F; Ji L; Wang W; Hua F; Zhan Y; Zou S; Yuan L; Ke Y; Min Z; Song D; Sun L; Chen H; Cheng Y
    Immunol Res; 2015 Mar; 61(3):269-80. PubMed ID: 25550089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose versus high-dose immunoglobulin for primary treatment of acute immune thrombocytopenic purpura in children: results of a prospective, randomized single-center trial.
    Benesch M; Kerbl R; Lackner H; Berghold A; Schwinger W; Triebl-Roth K; Urban C
    J Pediatr Hematol Oncol; 2003 Oct; 25(10):797-800. PubMed ID: 14528103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The abnormal function of CD39
    Lu Y; Cheng L; Li F; Ji L; Shao X; Wu B; Zhan Y; Liu C; Min Z; Ke Y; Sun L; Chen H; Cheng Y
    Ann Hematol; 2019 Aug; 98(8):1845-1854. PubMed ID: 31154474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of IVIG response in relation to Th1/Th2 cytokines in pediatricm immune thrombocytopenia.
    Chen YY; Zhou YQ; Zhao N; Zhang Y; Xu WQ; Tang YM
    Cytokine; 2019 Aug; 120():234-241. PubMed ID: 31129375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of Th1/Th2 and Th17/Treg by pDC/mDC imbalance in primary immune thrombocytopenia.
    Li Q; Liu Y; Wang X; Sun M; Wang L; Wang X; Liu Y; Fan W; Zhang K; Sui X; Guo X
    Exp Biol Med (Maywood); 2021 Aug; 246(15):1688-1697. PubMed ID: 33938255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The short-term predictive value of CD4
    Liu H; Liu X; Zhang G; Wang J; Naren D; Xie S; Li Y; Nie D; Li Z; Ma L
    Thromb Res; 2022 Oct; 218():157-168. PubMed ID: 36054980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.
    El Alfy MS; Mokhtar GM; El-Laboudy MA; Khalifa AS
    Acta Haematol; 2006; 115(1-2):46-52. PubMed ID: 16424649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different dosages of intravenous immunoglobulin (IVIg) in treating immune thrombocytopenia with long-term follow-up of three years: Results of a prospective study including 167 cases.
    Zhou Z; Qiao Z; Li H; Luo N; Zhang X; Xue F; Yang R
    Autoimmunity; 2016; 49(1):50-7. PubMed ID: 26525513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standard-dose intravenous anti-D immunoglobulin versus intravenous immunoglobulin in the treatment of newly diagnosed childhood primary immune thrombocytopenia.
    Papagianni A; Economou M; Tragiannidis A; Karatza E; Tsatra I; Gombakis N; Athanassiadou-Piperopoulou F; Athanasiou-Metaxa M
    J Pediatr Hematol Oncol; 2011 May; 33(4):265-9. PubMed ID: 21516022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential therapeutic benefit of resveratrol on Th17/Treg imbalance in immune thrombocytopenic purpura.
    Guo NH; Fu X; Zi FM; Song Y; Wang S; Cheng J
    Int Immunopharmacol; 2019 Aug; 73():181-192. PubMed ID: 31102993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcription Factor IRF4 Dysfunction Affects the Immunosuppressive Function of Treg Cells in Patients with Primary Immune Thrombocytopenia.
    Tang M; Cheng L; Li F; Wu B; Chen P; Zhan Y; Hua F; Min Z; Ke Y; Liu C; Yuan L; Sun L; Chen H; Ji L; Cheng Y
    Biomed Res Int; 2019; 2019():1050285. PubMed ID: 31380412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of intravenous immunoglobulin (2 g/kg totally) and single doses of anti-D immunoglobulin at 50 μg/kg, 75 μg/kg in newly diagnosed children with idiopathic thrombocytopenic purpura: Ankara hospital experience.
    Alioglu B; Ercan S; Tapci AE; Zengin T; Yazarli E; Dallar Y
    Blood Coagul Fibrinolysis; 2013 Jul; 24(5):505-9. PubMed ID: 23470649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteration in frequency and function of CD4⁺CD25⁺FOXP3⁺ regulatory T cells in patients with immune thrombocytopenic purpura.
    Arandi N; Mirshafiey A; Jeddi-Tehrani M; Shaghaghi M; Sadeghi B; Abolhassani H; Sharifian RA; Rahiminejad MS; Aghamohammadi A
    Iran J Allergy Asthma Immunol; 2014 Apr; 13(2):85-92. PubMed ID: 24338252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased TLR4 expression on monocytes may cause regulatory T cells abnormality in patients with primary immune thrombocytopenia.
    Hao Y; Li H; Li Y; Lyu M; Zhang D; Fu R; Guan Y; Wang S; Sun B; Dou X; Yang R
    Autoimmunity; 2017 Aug; 50(5):283-292. PubMed ID: 28412855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized study of IVIg and high-dose dexamethasone therapy for children with chronic idiopathic thrombocytopenic purpura.
    Hedlund-Treutiger I; Henter JI; Elinder G
    J Pediatr Hematol Oncol; 2003 Feb; 25(2):139-44. PubMed ID: 12571466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous immunoglobulin vs observation in childhood immune thrombocytopenia: a randomized controlled trial.
    Heitink-Pollé KMJ; Uiterwaal CSPM; Porcelijn L; Tamminga RYJ; Smiers FJ; van Woerden NL; Wesseling J; Vidarsson G; Laarhoven AG; de Haas M; Bruin MCA;
    Blood; 2018 Aug; 132(9):883-891. PubMed ID: 29945954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.